Abstract 5442: Terthighcells: key players in salivary gland homeostasis and regeneration after radiation therapy in adult mice

Abstract Salivary gland homeostasis and regeneration post-radiotherapy depend significantly on stem/progenitor cells. However, the lineage of SMG progenitor cells is not as well defined as in other normal organs, and better understanding of this population would be important for their future clinical application for tissue regeneration. Using a mouse strain expressing regulated CreERT2 recombinase from the endogenous Tert locus, we identify a distinct Terthigh cell population that are located in the ductal region throughout the submandibular gland (SMG), express ASCL3 (another progenitor cell marker) and can give rise to ductal cells during homeostasis. In contrast, Terthigh cells are found to repopulate both ductal and acinar cells at one year of tracing after radiotherapy. Terthigh cells from adult SMG retain self-renewal capacity when subjected in vitro culture, are resistant to radiation cell kill, and display enhanced proliferative activity post-radiation. Similarly, primary human SMG cells with high Tert expression display enhanced cell survival after radiotherapy. RNA sequencing reveals upregulation of the cell cycling and oxidative stress response pathways these cells after radiation. Mechanistically, Tert appears to modulate cell survival and ROS level in SMG spheres following radiation damage. Collectively, these data suggest that Terthigh cells constitute a novel subset of SMG progenitor cells located throughout the ductal region of the gland that can help to repopulate both ductal and acinar cells after RT damage. Citation Format: Li Guan, Vignesh Viswanathan, Sivakamasundari V, Hongbin Cao, Yuyan Jiang, Junfei Zhao, Deana R. Colburg, Patrick T. Neuhoefer, Yu Xu, Eyiwunmi E. Laseinde, Steven Artandi, Quynh-Thu Le. Terthighcells: key players in salivary gland homeostasis and regeneration after radiation therapy in adult mice [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 5442.